Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
BIOPOLIS, S.L. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, DURYEE, ALEXANDER MARSH, who is the busiest examiner. The activity is confined to 1 distinct art unit. This indicates a narrow prosecution footprint, as all current activity is consolidated under the assigned examiner and art unit.
The busiest examiner's workload of 1 pending action matches the total volume of the portfolio. This high level of concentration suggests that the company's immediate patent prospects are tied to the specific interpretations of the assigned individual. Navigating the 1 distinct art unit requires a strategy tailored to its specific culture, as there are no other pending matters to provide a broader perspective on current trends for this portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719647 | USE OF POSTBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ANXIETY DISORDERS | DURYEE, ALEXANDER MARSH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719647 | USE OF POSTBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ANXIETY DISORDERS | DURYEE, ALEXANDER MARSH | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18719647 | USE OF POSTBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ANXIETY DISORDERS | DURYEE, ALEXANDER MARSH | 1657 | §101§102§112DP | Non-Final OA | — | Pending | Jun 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial